Abstract
Radiotherapy-induced dermatitis (RID) is an inflammatory cutaneous disorder that is acquired as an adverse effect of undergoing radiotherapy. Skin microbiome dysbiosis has been linked to the outcomes of several dermatological diseases. To explore the skin microbiota of RID and deduce their underlying impact on the outcome of RID, cutaneous microbiomes of 78 RID patients and 20 healthy subjects were characterized by sequencing V1-V3 regions of 16S rRNA gene. In total, a significantly apparent reduction in bacterial diversity was detected in microbiomes of RID in comparison to controls. Overall, the raised Proteobacteria/ Firmicutes ratio was significantly linked to delayed recovery or tendency toward the permanence of RID (Kruskal Wallis: P = 2.66 × 10–4). Moreover, applying enterotyping on our samples stratified microbiomes into A, B, and C dermotypes. Dermotype C included overrepresentation of Pseudomonas, Staphylococcus and Stenotrophomonas and was markedly associated with delayed healing of RID. Strikingly, coexistence of diabetes mellitus and RID was remarkably correlated with a significant overrepresentation of Klebsiella or Pseudomonas and Staphylococcus. Metabolic abilities of skin microbiome could support their potential roles in the pathogenesis of RID. Cutaneous microbiome profiling at the early stages of RID could be indicative of prospective clinical outcomes and maybe a helpful guide for personalized therapy.
Similar content being viewed by others
Introduction
Worldwide, there is a raised incidence of cancer1. Recently, Egypt recorded an exponentially increased rate of cancer patients. Radiotherapy is substantially considered as a key element of treatment in breast cancer and nearly is applied to > 70% of cancer patients2,3,4,5.
Although the rapid advances in radiation oncology improved the effectiveness of cancer treatment, skin reactions, which are defined as radiation dermatitis, remain the most common adverse effect of radiation toxicity6. Overall, cutaneous dermatitis negatively affects individuals’ health and quality of life. Pathophysiology of cutaneous dermatitis was linked to a multitude of predisposing factors that could cause a disturbance in proinflammatory and profibrotic cytokines7,8. These factors include genetic and epigenetic predisposition in addition to arterial insufficiency, diabetes mellitus, chronic osteomyelitis, radiotherapy-induced dermatitis (RID), rheumatoid arthritis, skin tumors, trauma and venous ulcers1,9,10. Distinctly, the vast majority of cancer patients experience skin reactions upon radiation exposure. Several risk factors are assumed to directly trigger or influence the incidence and severity of RID. These risk factors may be intrinsic including age, ethnicity, gender, malnutrition, location and stage of the tumor, and concomitant diseases such as systemic inflammation and diabetes mellitus. While extrinsic factors include the kind and total dose of treatment, volume of treated area and radiotherapy technique11, in addition to bacterial infections12.
The anatomical and physiological structures of human skin represent the protective shield of the human body. The human skin is influenced by the surroundings and is the site where billions of microbial communities collectively constitute a unique ecosystem that constantly modulates host immunity and metabolism. The normal functions of human skin basically require integral collaborations between epidermal barriers, skin immunity and microbial inhabitants. Both the composition and structure of the microbial ecosystems associated with the human skin are influenced by several factors which include host-related such as age and gender, in addition to external stimuli as weather, lifestyle, and use of medicated preparations13,14.
Despite the skin microbiomes have been intensely investigated over the past years for their implication in several dermatological disorders, their roles in the pathogenesis and prognosis of RID demand comprehensive investigations. We aimed to provide new insight into the potential impact of skin microbiome on the prognosis of RID.
Methods and materials
Ethics statement
The present study was approved by the ethics committee of the Faculty of Pharmacy, Port Said University, Egypt (Reference no. A-6-2019). This study was carried out following the principles of the Declaration of Helsinki. Recruited patients in this study provided informed consent at sampling time.
Study design and recruitment of participants
This study was performed for over 16 months (between June 2019 and September 2020). Participants were prospectively enrolled at outpatient clinics of dermatology department, Al Mabarrah Health Insurance Hospital, Zagazig, Egypt. The prognosis of RID was identified by follow-up of patients for 12 months. Diagnosis and grading of RID were carried out according to CDC Cutaneous Radiation Injury: Fact Sheet for Physicians15,16. The inclusion criterion was mainly based on patients with newly diagnosed and grade 2 confirmed RID. The exclusion criteria were: (1) systemic antibiotic intake; (2) topical application of corticosteroids and antibiotics. Besides, healthy subjects were involved in the current study. All recruited patients provided informed consent prior to sampling.
Sample collection, DNA extraction and sequencing of 16S rRNA gene
Skin swabs were collected from patients by rubbing the site of RID with a premoistened swab (0.15 M NaCl with 0.1%Tween 20). Also, antecubital fossa, represents the moist sites, was rubbed by swab for collecting specimens from healthy subjects17. The collected swabs were used for genomic bacterial DNA extraction using DNeasy PowerSoil Kit Catalog No. 12888 (Qiagen, Valencia, USA) with previously reported modifications18. V1-V3 hypervariable regions of 16S rRNA gene were amplified using the following primers (underlined bases define adaptors): Forward Primer 5′ AATGATACGGCGACCACCGAGATCTACACATCGTACGTATGGTAATTC AATTACCGCGGCT GCTGG; Reverse Primer 5′ CAAGCAGAAGACGGCATACGAGATAACTCTCGAG TCAGTCA GCCGAGTTTGATCMTGGCTCAG19. Then, PCR amplicons were sequenced by Illumina MiSeq at IGA Technology Services (Udine, Italy).
Bioinformatic analyses of row reads of 16S rRNA
The analysis and classification of 16S rRNA reads were mainly based on ribosomal sequence variants (RSV). QIIME2 platform with DADA2 plugin was used for sequence preprocessing20, which included: trimming, filtering and denoising of row reads as previously described (maxEE = 2; truncation length for forward and reverse reads 270 and 210, respectively; Phred quality ≥ 25)21. Finally, high-resolution RSVs were generated by removing the potential chimeric sequences.
RDP’s naive Bayesian classifier was applied on representative RSVs for taxonomy assignment against SILVA SSU Ref NR dataset v.132 at 99% sequence similarity22,23.
Bacterial diversity was estimated using QIIME2 on the entire dataset without subsampling. Alpha diversity was determined using two approaches; regarding richness (number of observed species and Chao1 index) and evenness of communities (Shannon diversity index). The statistical significance of pairwise comparisons was assessed using unpaired Wilcoxon rank sum test, while multiple group comparisons were estimated using Kruskal–Wallis rank sum test and all P values were corrected using false discovery rate method (FDR)24. The core genus in our dataset was defined as the genus that was detected in 80% of all samples, while the core genus for each study group was defined as the genus that was present in all samples of this group.
Phylogenetic relatedness of bacterial communities was identified using both unweighted and weighted UniFrac matrices25. Similarity distances between cutaneous microbiomes were visualized by principal coordinates analysis (PCoA) based on weighted UniFrac distance matrix. Permutational Multivariate Analysis of Variance (Adonis R, package Vegan) was applied to define the significance of weighted UniFrac distance-based clustering of samples26.
To determine the dermotypes of cutaneous microbiomes, a widely used enterotyping pipeline was applied to all genera in our dataset. Clustering of samples and the optimum number of clusters were achieved using partitioning around medoids (PAM) algorithm, Jensen–Shannon divergence (JSD) and Calinski-Harabasz (CH) index27.
For predicting the functional profile of cutaneous microbiota, representative RSVs were employed for further taxonomic classification using UCLUST28 against Greengenes database (V 13.8)29 at a 97% identity using closed-reference script for OTU picking in QIIME, v 1.9.129. Functional potential of cutaneous microbiomes was predicted using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) for mapping the Kyoto Encyclopedia of Genes and Genome (KEGG) Orthology (KO) Database at level 330,31,32. LEfSe was applied to the metagenomic data to define the taxon or metabolic pathway (logarithmic LDA scores > 3.0 and α = 0.05) that were differentially abundant among healthy subjects and patients with RID (https://huttenhower.sph.harvard.edu/lefse/)33.
Correlations between either communities’ members or structure of microbiota and patient’s clinical data were defined by Spearman correlation coefficient (r ≥ ± 0.6, P ≤ 0. 01) using R package, Hamsic34. R packages; Phyloseq and ggpubr, were applied for calculation and plotting of diversity indices (https://rpkgs.datanovia.com/ggpubr/)35,36, while ggplot2 was used for graphical illustrations of results (http://userweb.eng.gla.ac.uk/umer.ijaz/bioinformatics/ecological.html)37.
Data availability
16S rRNA row reads of this study have been deposited in NCBI bioproject under accession number PRJNA665254 (http://www.ncbi.nlm.nih.gov/bioproject/665254) and biosamples (SAMN168624511: SAMN16862528).
Results
Patient’s characteristics
Ninety-eight subjects were included in this study (20 controls and 78 patients with RID). Patients’ data regarding clinical characteristics, demography and outcome were listed in Table 1 (Supplemental Table S1).
Preprocessing and analyses of 16S rRNA sequences
In total, 11,276,243 row sequences (average reads per sample = 11,564) were inputted in Qiime2 for merging, quality checking, removal of low quality reads (1,405,020 sequences, 12.46% of all dataset) and potential chimeric sequences (587,492 sequences, 5.21% of all dataset) that were resulted in 9,283,731high quality sequences that were used for downstream analyses.
Distinct taxonomic profile of cutaneous microbiomes related to RID
16S rRNA reads were taxonomically assigned to 19 phyla, 58 classes, 109 orders, 237 families, 658 genera and 4643 OTUs. In total, cutaneous microbiomes associated to RID showed a remarkable representation of certain bacterial taxa at different taxonomic levels that was in contrast to healthy subjects (Fig. 1). Phylum level analyses of RID microbiomes exhibited alternately significant predominance of Firmicutes and Proteobacteria (Mean relative abundance ± SD: 55.39 ± 25.07% and 32.45 ± 19.79%, respectively) in addition to relatively constant proportions of Actinobacteria (Mean relative abundance ± SD: 7.15 ± 5.18%). Classification of RID samples to seven groups, regarding the time required for recovery of RID, revealed significant representation and coexistence of Proteobacteria and Firmicutes (Kruskal Wallis; P = 2.58 × 10–7: Spearman; r = -0.68, P = 0.001) (Supplemental Table S2). Microbiomes associated to rapidly healed RID (2, 3, 4 weeks) were significantly accompanied by the predominance of Firmicutes over Proteobacteria (Mean relative abundance: 52.2% and 29.42%, respectively; Kruskal Wallis: P = 5.71 × 10–4). In contrast, microbiomes of chronic ulcers were significantly predominated by Proteobacteria and low abundance of Firmicutes (Mean relative abundance: 74.01% and 18.36%, respectively; Kruskal Wallis, P = 0.00083).
Reduced bacterial diversity characterize the shifts in cutaneous microbiomes of RID
Identification of bacterial diversity associated with RID was performed using both evenness and richness indices. Skin microbiomes of healthy subjects were significantly more diverse than those with RID (Wilcoxon test: P = 0011.47 × 10–5) (Fig. 2). Surprisingly, cutaneous microbiomes of RID showed a significant reduction in bacterial diversity in conjugation with a prolonged duration of RID (Kruskal Wallis, P = 0.00047). Cutaneous microbiomes of RID that turned to chronic ulcer had significantly reduced bacterial diversity in comparison to either healthy individuals or rapidly healed RID (Kruskal Wallis: P = 0.00093).
Both structure and composition of bacterial communities significantly drove the classification of cutaneous microbiomes to health-state based clustering (Fig. 3a). PCoA based on weighted UniFrac metrics have sorted RID associated samples to 7 particular clusters that were mainly based on the healing time of RID (Fig. 3b).
Relative proportions of core genera of healthy cutaneous microbiomes could potentially define the outcome of RID
Studying the structure of RID microbiomes at the family level unable to provide a deep understanding of the potential causative agent of RID. For instance, either Enterobacteriaceae or Staphylococcaceae were the most predominant families in several RID specimens, while genus level analysis was provided a clear separation of genera belonging to the previous families (Fig. 4a). In general, Klebsiella, Cutibacterium, Corynebacterium, Bacillus and Paracoccus were the dominant genera in healthy subjects. On the other hand, microbiomes of RID were generally inhabited with Klebsiella, Staphylococcus or Pseudomonas. Interestingly, microbiomes of RID that turned to chronic ulcers showed significant overrepresentation of Klebsiella or Pseudomonas, Cutibacterium and Stenotrophomonas. Also, the coexistence of Pseudomonas, Staphylococcus and Stenotrophomonas was significantly correlated with shifting of RID toward chronicity (Spearman; r = 0.87, P = 0.001).
Identification of the core genera of the entire dataset revealed that Klebsiella, Pseudomonas, Cutibacterium, Corynebacterium, Bacillus and uncultured Enterobacteriaceae were detected in all samples with variable abundance (Fig. 4b).
Tendency toward the development of radiotherapy-induced chronic ulcers was significantly linked to Dermotype C
Our genera were stratified into three dermotypes (Table 2). Dermotype C was characterized by the predominance of Pseudomonas, Staphylococcus and Stenotrophomonas over Klebsiella. Of note, although dermotype A in healthy individuals was composed of slightly dominant Klebsiella in addition to Bacillus, Cutibacterium and Staphylococcus, it was characterized by an overrepresentation of Klebsiella in RID. Moreover, both dermotype A in RID and dermotype C were significantly linked to delayed recovery and chronic ulcer formation in RID patients (Table 3).
Predominance of Klebsiella pneumoniae or co-existence of Pseudomonas aeruginosa and Staphylococcus aureus was significantly linked to RID
Species level analysis of RSVs revealed the significant enrichment of Klebsiella pneumoniae, Pseudomonas aeruginosa and Staphylococcus aureus in RID in comparison to healthy subjects (Mean relative abundance: 48.94% and 27.54%, respectively; Wilcoxon test: P = 0.00017). Additionally, the predominance of these species was accompanied by a slightly enriched representation of uncultured Enterobacteriaceae species, Klebsiella varicola, Stenotrophomonas maltophilia, Rothia dentocariosa and Acinetobacter johnsonii. Nevertheless, unclassified sequences represented about 21.83% of cutaneous microbiomes of controls, while in RID microbiomes they were constituted 1.69%. Strikingly, K. pneumoniae was negatively correlated to P. aeruginosa in all study groups (Spearman: r = − 0.79; P = 0.0008). Also, the strongest correlations were detected between P. aeruginosa, S. aureus and S. maltophilia.
Overall functional potential of the cutaneous microbiome was likely to contribute to the pathogenesis of RID
The collective metabolic functional profile of RID microbiome was significantly associated with the overrepresentation of metabolic pathways that could be attributed to impairments in epidermal integrity, alteration in pH and supporting microbial survival such as lipid metabolism, histidine metabolism, enhanced bacterial invasion of epithelial cells, signaling molecules of bacterial toxins, hedgehog signaling pathway, nitrogen metabolism and peptidases (Supplemental Fig. S1).
Discussion
RID represents a challenge for clinicians, especially it is nearly acquired by all cancer patients who undergo radiotherapy and is regarded as an extra section in healthcare expenditure. Till now, a detailed characterization of microbial contribution to the bioburden of skin disorders is exclusively concerned with studying atopic dermatitis, psoriasis, diabetic foot and burns. Furthermore, the major concern is mainly directed to the culture-based approaches that are restricted to a scanty number of microorganisms, and consequentially override the integral role of the entire community38,39.
In accordance with the well-established concepts, concerning alpha diversity, about the evident reduction in the microbial diversity of dermatological disorders such as atopic dermatitis and psoriasis, the microbiome of RID showed minimal bacterial diversity in comparison to controls21,40,41,42,43. Also radiotherapy was accompanied by significant reduction in microbial diversity of salivary microbiome44. The pathophysiology of RID may include epidermal disturbances, cutaneous injuries, reduced blood supply, impairment in cellular repair and misdirected cutaneous immunity. These factors could be explaining the lowered diversity of RID as a result of predominance of certain opportunistic pathogens over the beneficial ones that subsequently interfere with the synthesis of natural antimicrobial peptides and cutaneous immunomodulation45,46. Another remarkable observation is the recovery rates of RID that were positively correlated to bacterial diversity at different taxonomy levels. These observations were matched with the protective roles of cutaneous microbiota in the maintenance of epidermal integrity45. The impact of restoring skin microbiome on wound healing has been revealed by a study on the animal model47.
It is noteworthy that the UniFrac-based similarity distances between RID microbiomes significantly assorted the specimens to particularly separate patterns depending on the recovery time. A recent study revealed the significant stable temporal shifts of nasopharyngeal microbiota during the period of radiotherapy treatment48. Thus, the composition and structure of microbiomes at beginning of RID could reflect the prospective outcome.
Taxonomy profiling of cutaneous microbiota associated to RID highlighted the massive prevalence of Proteobacteria or Firmicutes that is in agreement with the overrepresentation of taxa belonging to them in common skin disorders such acne, atopic dermatitis and psoriasis21,43,49.
One of the interesting findings is the significant association between diabetes mellitus and developing a chronic ulcer in RID patients (Spearman: r = 0.86; P = 0.001). Diabetes mellitus is a metabolic disorder that is significantly linked to developing chronic wounds due to the impairments in wound healing phases that provides favorable conditions for either opportunistic residents or pathogenic bacteria50. Also, colonization of wounds with certain microorganisms was strongly correlated to the persistence of wound via organism induced body changes that include epidermal barrier integrity, alteration in pH and dysregulation of the immune system51,52,53. Overall, developing chronic ulcer in diabetic patients with RID could potentially depend on the colonizing microorganisms through intensifying the epidermal disturbances produced by diabetes mellitus.
The main interesting finding of the present study is the collective correlations between community members. While Klebsiella genus was inversely correlated to other predominant genera in all datasets, Pseudomonas, Staphylococcus and Stenotrophomonas have exhibited a significant coexistence especially in prolonged RID and chronic ulcers (Supplemental Table S3). Although the impact of coinfection with S. aureus and P. aeruginosa on the clinical outcome of cystic fibrosis is controversial, the comparisons with mono-infection of S. aureus or P. aeruginosa showed that the pair coexisting was significantly associated with prolonged hospitalization and exacerbation of the disease54. Also, the bidirectional interplay between this pair was manifested in the inhibition of phagocytosis, in addition to the promotion of staphylococcal biofilm formation by P. aeruginosa54,55. Additionally, Stenotrophomonas maltophilia was detected in our samples with significant prevalence especially in RID patients. S. maltophilia has emerged as an opportunistic pathogen with global concerns, due to its significant association with the high crude mortality in pneumonia and bacteremia of immunosuppressed patients56. S. maltophilia was also reported to cause wound infections, soft tissue infections, bone and joint infections, and cellulitis57,58. Interestingly, in our study, the coexistence of S. maltophilia and P. aeruginosa was strongly correlated to develop chronic ulcers in RID. This observation was in agreement with the previously reported cooperative pathogenicity of this pair in cystic fibrosis59.
As expected in the cutaneous microbiome, Staphylococcus genus was defined as a core genus in healthy and diseased groups. Although S. aureus was significantly enriched in RID microbiomes, it was overrepresented in the rapidly healed RID. These findings were matched with the previous study which reported that the S. aureus infection was conjugated with limited exacerbations and a short duration of hospitalization54.
Notably, K. pneumoniae showed fluctuated representation in our specimens. In microbiomes of RID, K. pneumoniae was significantly overrepresented especially in samples that turned to a chronic ulcer, and its abundance was strongly linked to diabetes mellitus. As it is known that K. pneumoniae have been implicated in liver abscess, meningitis and psoas abscess60. Furthermore, K. pneumoniae may harbor diverse virulence characteristics including capsules, multidrug resistance and virulence factors that enhance invasion and promote epidermal deteriorations61,62. The coexistence of these characteristics and diabetes mellitus could boost epidermal damage, aggravate the inflammatory processes and retard the repair of the epidermal barrier.
The limitations of this study are the slightly small sample size of each group, dependence on unculturable approach, lack of microbiome characterization at different sampling time and isolation of causative agents in order to define their virulence characteristics including antimicrobial resistance patterns.
Conclusions
We have studied the microbiome of patients with RID in order to accentuate the underlying bacterial structure and to provide new insight about the potential role of microbiota as an influential factor in pathogenesis and clinical outcome of RID as well. A notable positive correlation has existed between bacterial diversity and recovery rates of RID. The overwhelming predominance of Klebsiella or coexistence of Pseudomonas, Staphylococcus and Stenotrophomonas potentially prompt the chronic ulcer formation in RID patients. Cutaneous microbiome profiling at the early stages of RID could be indicative of the prospective clinical outcomes and might be a helpful guide for personalized therapy and management of RID. Finally, shifts in the structure and prevalence of cutaneous microbiota that accompany the RID could support the candidate role of microbial dysbiosis in the pathogenesis of RID.
References
Siddiqui, A. R. & Bernstein, J. M. Chronic wound infection: Facts and controversies. Clin. Dermatol. 28, 519–526. https://doi.org/10.1016/j.clindermatol.2010.03.009 (2010).
Baum, C. et al. Regional variation of pancreatic cancer incidence in the Nile Delta Region of Egypt over a twelve-year period. J. Cancer Epidemiol. https://doi.org/10.1155/2020/6031708 (2020).
Abo-Touk, N. Cancer registry report in Mansoura University Hospital, Egypt in 2015. Forum Clin. Oncol. https://doi.org/10.2478/fco-2019-0003 (2020).
Arafa, M. A., Rabah, D. M. & Farhat, K. H. Rising cancer rates in the Arab World: Now is the time for action. Eastern Mediterranean Health J. = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq 26, 638–640. https://doi.org/10.26719/emhj.20.073 (2020).
Shimaa, A. E., Refaat, R. S., Fadia, A. M. & Asmaa, T. Pattern of Malignant Tumors among Cancer Patients during the Year 2014 in Minia Governorate, Egypt. Egypt. J. Community Med 38, (2020).
Hickok, J. T., Morrow, G. R., Roscoe, J. A., Mustian, K. & Okunieff, P. Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J. Pain Symptom Manage. 30, 433–442. https://doi.org/10.1016/j.jpainsymman.2005.04.012 (2005).
Wei, J. et al. Radiation-induced skin reactions: Mechanism and treatment. Cancer Manag. Res. 11, 167–177. https://doi.org/10.2147/CMAR.S188655 (2018).
Haase, O. & Rodemann, H. P. Fibrosis and cytokine mechanisms: Relevant in hadron therapy?. Radiother. Oncol. 73(Suppl 2), S144-147. https://doi.org/10.1016/s0167-8140(04)80037-9 (2004).
Mendonça, A. C. et al. Thermographic characterization of cutaneous ulcers of different etiologies. J. Med. Syst. 44, 160. https://doi.org/10.1007/s10916-020-01612-8 (2020).
Abbade, L. P. & Lastória, S. Venous ulcer: Epidemiology, physiopathology, diagnosis and treatment. Int. J. Dermatol. 44, 449–456. https://doi.org/10.1111/j.1365-4632.2004.02456.x (2005).
Spałek, M. Chronic radiation-induced dermatitis: Challenges and solutions. Clin. Cosm. Investig. Dermatol. 9, 473–482. https://doi.org/10.2147/CCID.S94320 (2016).
Hill, A., Hanson, M., Bogle, M. A. & Duvic, M. Severe radiation dermatitis is related to Staphylococcus Aureus. Am. J. Clin. Oncol. 27, 15. https://doi.org/10.1097/01.COC.0000071418.12121.C2 (2004).
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-bacterial mutualism in the human intestine. Science 307, 1915–1920. https://doi.org/10.1126/science.1104816 (2005).
Dimitriu, P. A. et al. New insights into the intrinsic and extrinsic factors that shape the human skin microbiome. mBio 10, e00839-e1819. https://doi.org/10.1128/mBio.00839-19 (2019).
Centers for Disease, C. & Prevention. Cutaneous Radiation injury: Fact Sheet for Physicians. http://www.bt.cdc.gov/radiation/arsphysicianfactsheet.asp (2008).
Hymes, S. R., Strom, E. A. & Fife, C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J. Am. Acad. Dermatol. 54, 28–46. https://doi.org/10.1016/j.jaad.2005.08.054 (2006).
Grice, E. A. et al. Topographical and temporal diversity of the human skin microbiome. Science 324, 1190. https://doi.org/10.1126/science.1171700 (2009).
Ramadan, M., Solyman, S., Taha, M. & Hanora, A. Preliminary characterization of human skin microbiome in healthy Egyptian individuals. Cell Mol. Biol. 62, 21–27 (2016).
Allen, H. K. et al. Pipeline for amplifying and analyzing amplicons of the V1–V3 region of the 16S rRNA gene. BMC Res. Notes 9, 380. https://doi.org/10.1186/s13104-016-2172-6 (2016).
Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583. https://doi.org/10.1038/nmeth.3869 (2016).
Ramadan, M. et al. Skin microbiome differences in atopic dermatitis and healthy controls in Egyptian children and adults, and association with serum immunoglobulin E. OMICS 23, 247–260. https://doi.org/10.1089/omi.2019.0011 (2019).
Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261–5267. https://doi.org/10.1128/aem.00062-07 (2007).
Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590-596. https://doi.org/10.1093/nar/gks1219 (2013).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x (1995).
Lozupone, C., Lladser, M. E., Knights, D., Stombaugh, J. & Knight, R. UniFrac: An effective distance metric for microbial community comparison. ISME J. 5, 169–172. https://doi.org/10.1038/ismej.2010.133 (2011).
Anderson, M. J. A new method for non-parametric multivariate analysis of variance. Austral. Ecol. 26, 32–46. https://doi.org/10.1111/j.1442-9993.2001.01070.pp.x (2001).
Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics (Oxford, England) 26, 2460–2461. https://doi.org/10.1093/bioinformatics/btq461 (2010).
McDonald, D. et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 6, 610–618. https://doi.org/10.1038/ismej.2011.139 (2012).
Langille, M. G. et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31, 814–821. https://doi.org/10.1038/nbt.2676 (2013).
Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27–30. https://doi.org/10.1093/nar/28.1.27%JNucleicAcidsResearch (2000).
Kanehisa, M. et al. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 42, D199–D205. https://doi.org/10.1093/nar/gkt1076%JNucleicAcidsResearch (2013).
Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60–R60. https://doi.org/10.1186/gb-2011-12-6-r60 (2011).
Harrell, F. E. & Dupont, C. J. R. P. V. Hmisc: Harrell Miscellaneous. R Package Version 3, (2008).
McMurdie, P. J. & Holmes, S. phyloseq: An R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217. https://doi.org/10.1371/journal.pone.0061217 (2013).
Kassambara, A. ggpubr: “ggplot2” Based Publication Ready Plots. R Package Version 0.2 (2018).
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer Science & Business Media, Berlin, 2009).
Metzker, M. L. Emerging technologies in DNA sequencing. Genome Res. 15, 1767–1776. https://doi.org/10.1101/gr.3770505 (2005).
Zhang, J., Chiodini, R., Badr, A. & Zhang, G. The impact of next-generation sequencing on genomics. J. Genet. Genom. 38, 95–109. https://doi.org/10.1016/j.jgg.2011.02.003 (2011).
Byrd, A. L. et al. Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Sci. Transl. Med. 9, 15. https://doi.org/10.1126/scitranslmed.aal4651 (2017).
Kong, H. H. et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 22, 850–859. https://doi.org/10.1101/gr.131029.111 (2012).
Elsherbiny, N. M. et al. Autoimmune hepatitis: Shifts in gut microbiota and metabolic pathways among Egyptian patients. Microorganisms 8, 1011. https://doi.org/10.1586/14787210.2015.102329110.3390/microorganisms8071011 (2020).
Farahmand, S. Skin Microbiome Handbook 143–169 (Wiley, New York, 2020).
Kumpitsch, C., Moissl-Eichinger, C., Pock, J., Thurnher, D. & Wolf, A. Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma. Sci. Rep. 10, 16582. https://doi.org/10.1038/s41598-020-73515-0 (2020).
Sanford, J. A. & Gallo, R. L. Functions of the skin microbiota in health and disease. Semin. Immunol. 25, 370–377. https://doi.org/10.1016/j.smim.2013.09.005 (2013).
Kim, B. E. & Leung, D. Y. M. Significance of skin barrier dysfunction in atopic dermatitis. Allergy Asthma Immunol. Res. 10, 207–215. https://doi.org/10.4168/aair.2018.10.3.207 (2018).
Zhang, M. et al. Oral antibiotic treatment induces skin microbiota dysbiosis and influences wound healing. Microb. Ecol. 69, 415–421. https://doi.org/10.1007/s00248-014-0504-4 (2015).
Huang, T. et al. Radiation therapy-induced changes of the nasopharyngeal commensal microbiome in nasopharyngeal carcinoma patients. Int. J. Radiat. Oncol. Biol. Phys. https://doi.org/10.1016/j.ijrobp.2020.08.054 (2020).
Lee, Y. B., Byun, E. J. & Kim, H. S. Potential role of the microbiome in acne: A comprehensive review. J. Clin. Med. 8, 987. https://doi.org/10.3390/jcm8070987 (2019).
Wolcott, R. et al. Microbiota is a primary cause of pathogenesis of chronic wounds. J. Wound Care 25, S33-s43. https://doi.org/10.12968/jowc.2016.25.Sup10.S33 (2016).
Lamendella, R., Domingo, J. W., Ghosh, S., Martinson, J. & Oerther, D. B. Comparative fecal metagenomics unveils unique functional capacity of the swine gut. BMC Microbiol. 11, 103. https://doi.org/10.1186/1471-2180-11-103 (2011).
Erickson, A. R. et al. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn’s disease. PLoS ONE 7, e49138. https://doi.org/10.1371/journal.pone.0049138 (2012).
Pang, M. et al. Changes in foot skin microbiome of patients with diabetes mellitus using high-throughput 16S rRNA gene sequencing: A case control study from a single center. Med. Sci. Monit. 26, e921440–e921440. https://doi.org/10.12659/MSM.921440 (2020).
Briaud, P. et al. Impact of coexistence phenotype between Staphylococcus aureus and Pseudomonas aeruginosa isolates on clinical outcomes among cystic fibrosis patients. Front. Cell. Infect. Microbiol. 10, 266. https://doi.org/10.3389/fcimb.2020.00266 (2020).
Armbruster, C. R. et al. Staphylococcus aureus Protein A mediates interspecies interactions at the cell surface of Pseudomonas aeruginosa. MBio 7, 16. https://doi.org/10.1128/mBio.00538-16 (2016).
Brooke, J. S. Stenotrophomonas maltophilia: An emerging global opportunistic pathogen. Clin. Microbiol. Rev. 25, 2–41. https://doi.org/10.1128/CMR.00019-11 (2012).
Falagas, M. E., Kastoris, A. C., Vouloumanou, E. K. & Dimopoulos, G. Community-acquired Stenotrophomonas maltophilia infections: A systematic review. Eur. J. Clin. Microbiol. Infect. Dis. 28, 719–730. https://doi.org/10.1007/s10096-009-0709-5 (2009).
Nag, F., De, A., Banerjee, K. & Chatterjee, G. Non healing leg ulcer infected with Stenotrophomonas maltophilia: First reported case from India. Int. Wound J. 10, 356–358. https://doi.org/10.1111/j.1742-481X.2012.00938.x (2013).
Pompilio, A. et al. Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm. Front. Microbiol. 6, 951. https://doi.org/10.3389/fmicb.2015.00951 (2015).
Chang, C. M., Ko, W. C., Lee, H. C., Chen, Y. M. & Chuang, Y. C. Klebsiella pneumoniae psoas abscess: Predominance in diabetic patients and grave prognosis in gas-forming cases. J. Microbiol. Immunol. Infect. 34, 201–206 (2001).
Lin, C.-J. et al. Repeated bacteremia with subsequent septic arthritis caused by Klebsiella pneumoniae capsular serotype K57 in a patient with diabetes. Clin. Infect. Dis. 49, 1284–1286. https://doi.org/10.1086/605689 (2009).
Paczosa, M. K. & Mecsas, J. Klebsiella pneumoniae: Going on the offense with a strong defense. Microbiol. Mol. Biol. Rev. 80, 629–661. https://doi.org/10.1128/MMBR.00078-15 (2016).
Funding
This research received no external funding.
Author information
Authors and Affiliations
Contributions
Conceptualization: M.R, H.F.H., M.S; Data curation: M.R, M.S, A.A.A.; Formal analysis: M.R., M.S, A.A.A.; Methodology: M.R., H.F.H, M.S, M.M.S., M.E.A.; Software: M.R., M.S., A.A.A.; Validation: M.R., M.S., M.M.S, M.E.A.; Visualization: M.R., M.S.; Writing—original draft M.R., M.S., M.M.S, M.E.A., A.A.A.; Writing—review & editing: M.R., H.F.H., M.S., M.M.S, M.E.A, A.A.A. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ramadan, M., Hetta, H.F., Saleh, M.M. et al. Alterations in skin microbiome mediated by radiotherapy and their potential roles in the prognosis of radiotherapy-induced dermatitis: a pilot study. Sci Rep 11, 5179 (2021). https://doi.org/10.1038/s41598-021-84529-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-021-84529-7
This article is cited by
-
Staphylococcus-aureus-Kolonisation als Risikofaktor der akuten Strahlenreaktion an der Haut
Strahlentherapie und Onkologie (2024)
-
Predicting acute radiation dermatitis in breast cancer: a prospective cohort study
BMC Cancer (2023)
-
Role of the microbiota in response to and recovery from cancer therapy
Nature Reviews Immunology (2023)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.